CTRI/2020/07/026700尚未招募未知
A randomized placebo controlled multicentric study to evaluate the efficacy and safety of Ayurvedic formulation as an immunomodulator in reducing the risk of COVID 19 infection or severe stage coronavirus disease in Healthcare workers involved in care of patients with Coronavirus disease
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1 18 years or older
- •2 If an individual has come in close contact with someone who has been diagnosed with COVID 19 with last exposure within the last 4 days and do not have any symptoms or
- •3 A healthcare worker involved in care of patients with Coronavirus disease
排除标准
- •1 Immunocompromised patients or patients receiving immuno-compromised medications
- •2 Patients with active malignancy or undergoing anticancer therapies
- •3 Pregnant women or women who are breastfeeding
- •4 Consideration by the investigator for any reason that the subject is an unsuitable
- •5 candidate to receive study treatment
- •Patients not willing to participate in study
研究者
相似试验
已完成
不适用
A multicentre randomised double-blind, double-dummy placebo-controlled study to assess the efficacy, safety and cost utility of Probiotic prophylaxis of spinal cord injury Urinary Tract Infection. A Therapeutic Trial. (ProSCIUTTU)People with spinal cord injury suffering from recurrent urinary tract infection resulting from multi-resistant organisms.People with stable multiple sclerosis or cerebral vascular disease, with documented neurogenic bladder on video urodynamic assessment, who also suffer from recurrent urinary tract infection resulting from multi-resitant organisms.Renal and Urogenital - Other renal and urogenital disordersInfection - Studies of infection and infectious agentsNeurological - Other neurological disordersACTRN12610000512022Dr Bon San Bonne Lee207
进行中（未招募）
不适用
A Multicentre Randomised Placebo-controlled Study to Assess the Efficacy and Safety of a Single Administration of Ferric Carboxymaltose (1,000 mg iron) in Improving Fatigue Symptoms in Iron-deficient Non-anaemic (IDNA) Women of Child Bearing AgeEUCTR2009-017737-21-ATVifor Pharma288
进行中（未招募）
不适用
A Multicentre Randomised Placebo-controlled Study to Assess the Efficacy and Safety of a Single Administration of Ferric Carboxymaltose (1,000 mg iron) in Improving Fatigue Symptoms in Iron-deficient Non-anaemic (IDNA) Women of Child Bearing AgeEUCTR2009-017737-21-SEVifor Pharma288
进行中（未招募）
不适用
A Multicentre Randomised Placebo-controlled Study to Assess the Efficacy and Safety of a Single Administration of Ferric Carboxymaltose (1,000 mg iron) in Improving Fatigue Symptoms in Iron-deficient Non-anaemic (IDNA) Women of Child Bearing AgeTreatment of iron deficient non anaemic women with ferric carboxymaltose.MedDRA version: 12.1Level: LLTClassification code 10022970Term: Iron deficiencyEUCTR2009-017737-21-DEVifor Pharma288
进行中（未招募）
1 期
Will Lactoferrin supplements prevent infections in premature babies?ate onset invasive infection in very preterm infantsEUCTR2012-004260-22-GBniversity of Oxford2,203